Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature
Background and objectives. Familial Mediterranean fever (FMF) is an autosomal-recessive auto-inflammatory disorder characterized by recurrent episodes of fever with serositis. Sacroiliitis associated with FMF is very rare, especially in children. We aimed to describe the demographic, clinical, laboratory features, and treatment responses of pediatric patients with FMF -related sacroiliitis. Methods. The study consisted of seven pediatric patients younger than 16 years, diagnosed with sacroiliitis associated with FMF between 2010 and 2017. Medical records of patients were retrospectively evaluated. Sacroiliitis was diagnosed based on magnetic resonance imaging. We also reviewed previous studies of FMF related sacroiliitis. Results. Five of the seven patients (male:female ratio of 5:2) had a M694V (homozygous) mutation, one patient had a M694V (heterozygous) mutation, and one patient had a V726A (heterozygous) mutation. All patients were HLA-B27 negative. One of the cases achieved remission with colchicine plus non-steroidal anti-inflammatory drug treatment, and one patient’s symptoms were managed by the addition of sulfasalazine. Four patients responded to etanercept treatment, and one patient’s symptoms were suppressed with canakinumab. Conclusion. Sacroiliitis can be seen in pediatric FMF patients suffering with inflammatory back pain. This manifestation generally occurs in FMF patients who have M694V mutation. Etanercept could likely show a beneficial effect in patients who are resistant to disease modifying anti-rheumatic drugs and non-steroidal anti-inflammatory drugs. In addition, canakinumab treatment should be considered as a successful alternative therapy in this rare group of patients.
___
1. Onen F. Familial Mediterranean fever. Rheumatol Int 2006; 26: 489-496.2. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-253.
3. Bernot A, Clepet C, Dasilva C, et al; The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
4. Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM 1997; 90: 37-43.
5. Balaban B, Yasar E, Ozgul A, Dincer K, Kalyon TA. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int 2005; 25: 641- 644.
6. Lehman TJ, Hanson V, Kornreich H, Peters RS, Schwabe AD. HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood. Pediatrics 1978; 61: 423-426.
7. Zochling J, Braun J. Assessment of ankylosing spondylitis. Clin Exp Rheumatol 2005; 23(Suppl 39): S133-S141.
8. Sönmez HE, Batu ED, Demir S, Bilginer Y, Özen S. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol 2017; 35(Suppl 108): 124-127.
9. Akar S, Soysal O, Balci A, et al. High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their firstdegree relatives: further evidence for the connection. Arthritis Res Ther 2013; 15: R21.
10. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 1974; 291: 932- 934.
11. Padeh S, Gerstein M, Berkun Y. Colchicine is a safe drug in children with familial Mediterranean fever. J Pediatr 2012; 161: 1142-1146.
12. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2001; 41: 265-271.
13. Ozgocmen S, Ozçakar L, Ardicoglu O, Kocakoc E, Kaya A, Kiris A. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol 2006; 25: 83-87.
14. Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997; 27: 67-72.
15. Demirag MD, Ozturk MA, Goker B, Haznedaroglu S. Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever. Rheumatol Int 2008; 29: 77-79.
16. Borman P, Gökoğlu F, Taşbaş O, Yilmaz M, Yorgancioğlu ZR. Familial Mediterranean feverrelated spondyloarthropathy. Singapore Med J 2009; 50: e116-e119.
17. Erten S, Erzurum C, Altunoglu A. Three family members with familial Mediterranean fever carrying the M694V mutation showed different clinical presentations. Intern Med 2012; 51: 1765-1768.
18. Bilgen SA, Kilic L, Akdogan A, et al. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment. J Clin Rheumatol 2011; 17: 358-362.
19. Estublier C, Stankovic Stojanovic K, Bergerot JF, Broussolle C, Sève P. Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinra. Joint Bone Spine 2013; 80: 645-649.
20. Varan O, Kucuk H, Tufan A. Anakinra for the treatment of familial Mediterranean fever-associated spondyloarthritis. Scand J Rheumatol 2016; 45: 252- 253.
21. Sahin A, Yetişgin A, Sahin M. Rheumatoid arthritis and familial mediterranean fever or sacroiliitis accompanied by FMF. Case Rep Rheumatol 2013; 2013: 636713.
22. Ugan Y, Doğru A, Şencan H, Şahin MF, Tunç ŞE. Sacroiliitis and polyarteritis nodosa in a patient with familial mediterranean fever. Case Rep Med 2016; 2016: 5134546.
23. Eifan AO, Ozdemir C, Aydogan M, Gocmen I, Bahceciler NN, Barlan IB. Incomplete attack and protracted sacroiliitis: an unusual manifestation of FMF in a child. Eur J Pediatr 2007; 166: 383-384.
24. Erten S, Erten SF, Altunoglu A. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF. Rheumatol Int 2012; 32: 1095-1097.
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Children with lymphoma presenting with hemophagocytic lymphohistiocytosis
Tekin AKSU, Turan BAYHAN, Belgin GÜLHAN, Selma ÇAKMAKÇI, Ayşe Selcen OĞUZ, Neşe YARALI, Namık Yaşar ÖZBEK, İnci ERGÜRHAN İLHAN
Çiğdem AKYOL BEYOĞLU, Pınar KENDİGELEN, İlhan BEYOĞLU, Fatiş ALTINDAŞ, Sebuh KURUĞOĞLU, Güner KAYA
Sinem Gülcan KERSİN, Turgut BOZAN, Hülya ÖZDEMİR, Hülya Selva BİLGEN, Güner SÖYLETİR, Aslı MEMİŞOĞLU, Eren ÖZEK
A rare case of syndromic severe congenital neutropenia: JAGN1 mutation
Funda ÇİPE, Çiğdem AYDOĞMUŞ, Avniye Kübra BASKIN, Gonca KESKİNDEMİRCİ, Wojciech GARNCARZ, Kaan BOZTUĞ
Aortic balloon valvuloplasty and mid-term results in newborns: a single center experience
Birgül VARAN, Kahraman YAKUT, İlkay ERDOĞAN, Murat ÖZKAN, Kürşad TOKEL
Maternal and fetal tuberous sclerosis complex: a case report questioning clinical approach
Özge Sürmeli ONAY, Adviye ÇAKIL SAĞLIK, Pelin KOSGER, Zeynep SARAÇOĞLU, Uğur TOPRAK, Birsen UCAR, AYŞE NESLİHAN TEKİN
Clinical manifestation and outcomes of children with hypertrophic cardiomyopathy in Kosovo
Ramush A. BEJIQI, Ragip RETKOCERI, Naim ZEKA, Armend VUÇİTERNA, Aferdita MUSTAFA, Arlinda MALOKU, Rinor BEJIQI
BERİL DİLBER, Tülay KAMAŞAK, İLKER EYÜBOĞLU, Mehmet KOLA, Ahmet Taner UYSAL, Haluk SARIHAN, Hatice Sonay YALÇIN CÖMERT, Elif SAĞ, Ali CANSU
Mustafa ÇAKAN, Nuray AKTAY AYAZ, Şerife Gül KARADAĞ
Özlem TEZOL, Fatih SAĞCAN, Pelin ÖZCAN KARA, Elvan Çaglar ÇITAK